Free Trial

ProVen VCT (LON:PVN) Reaches New 52-Week Low - What's Next?

ProVen VCT logo with Financial Services background

Key Points

  • ProVen VCT's stock price reached a new 52-week low of GBX 57 ($0.77), marking a 2.6% decline from the previous close of GBX 58.50 ($0.79).
  • The company reported an earnings per share (EPS) of GBX 0.20 ($0.00) for the last quarter, with a return on equity of 5.22% and a net margin of 67.04%.
  • ProVen VCT specializes in investing in emerging growth stage companies and does not engage in startup investments, focusing instead on small to medium-sized businesses.
  • Looking to export and analyze ProVen VCT data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

ProVen VCT (LON:PVN - Get Free Report) shares reached a new 52-week low during trading on Tuesday . The stock traded as low as GBX 57 ($0.77) and last traded at GBX 57 ($0.77), with a volume of 14630 shares traded. The stock had previously closed at GBX 58.50 ($0.79).

ProVen VCT Stock Down 2.6%

The company has a market cap of £155.07 million, a price-to-earnings ratio of 16.39 and a beta of 0.02. The firm has a 50-day simple moving average of GBX 58.58 and a 200 day simple moving average of GBX 59.

ProVen VCT (LON:PVN - Get Free Report) last released its earnings results on Monday, June 9th. The company reported GBX 0.20 ($0.00) earnings per share (EPS) for the quarter. ProVen VCT had a return on equity of 5.22% and a net margin of 67.04%.

About ProVen VCT

(Get Free Report)

ProVen VCT plc is a venture capital trust specializing in emerging growth stage investment,expansion and management buyouts. The fund invests in small and medium sized smaller companies. It does not invest in startups. It seeks to invest in non-qualifying investments including cash, liquidity funds, fixed interest securities, debt and debt related securities in growth companies and non-qualifying venture capital investments.

Further Reading

Should You Invest $1,000 in ProVen VCT Right Now?

Before you consider ProVen VCT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProVen VCT wasn't on the list.

While ProVen VCT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom
3 Growth Stock Winners to Watch And 3 to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines